Cargando…

Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population

AIMS: With prevalence of hepatocellular carcinoma (HCC) in low-risk population (LRP), establishing a non-invasive diagnostic strategy becomes increasingly urgent to spare unnecessary biopsies in this population. The purposes of this study were to find characterisics of HCC and to establish a proper...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Zonglin, Peng, Zhenpeng, Zou, Yujian, Xiao, Han, Li, Bin, Zhou, Qian, Chen, Shuling, Xu, Lixia, Shen, Jingxian, Mo, Yunxian, Peng, Sui, Kuang, Ming, Long, Jianting, Feng, Shi-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238050/
https://www.ncbi.nlm.nih.gov/pubmed/35761201
http://dx.doi.org/10.1186/s12885-022-09812-w
_version_ 1784736941242056704
author Xie, Zonglin
Peng, Zhenpeng
Zou, Yujian
Xiao, Han
Li, Bin
Zhou, Qian
Chen, Shuling
Xu, Lixia
Shen, Jingxian
Mo, Yunxian
Peng, Sui
Kuang, Ming
Long, Jianting
Feng, Shi-Ting
author_facet Xie, Zonglin
Peng, Zhenpeng
Zou, Yujian
Xiao, Han
Li, Bin
Zhou, Qian
Chen, Shuling
Xu, Lixia
Shen, Jingxian
Mo, Yunxian
Peng, Sui
Kuang, Ming
Long, Jianting
Feng, Shi-Ting
author_sort Xie, Zonglin
collection PubMed
description AIMS: With prevalence of hepatocellular carcinoma (HCC) in low-risk population (LRP), establishing a non-invasive diagnostic strategy becomes increasingly urgent to spare unnecessary biopsies in this population. The purposes of this study were to find characterisics of HCC and to establish a proper non-invasive method to diagnose HCC in LRP. METHODS: A total of 681 patients in LRP (defined as the population without cirrhosis, chronic HBV infection or HCC history) were collected from 2 institutions. The images of computed tomography (CT) and magnetic resonance imaging (MRI) were manually analysed. We divided the patients into the training cohort (n = 324) and the internal validating cohort (n = 139) by admission time in the first institution. The cohort in the second institution was viewed as the external validation (n = 218). A multivariate logistic regression model incorporating both imaging and clinical independent risk predictors was developed. C-statistics was used to evaluate the diagnostic performance. RESULTS: Besides the major imaging features of HCC (non-rim enhancement, washout and enhancing capsule), tumor necrosis or severe ischemia (TNSI) on imaging and two clinical characteristics (gender and alpha fetoprotein) were also independently associated with HCC diagnosis (all P < 0.01). A clinical model (including 3 major features, TNSI, gender and AFP) was built to diagnose HCC and achieved good diagnostic performance (area under curve values were 0.954 in the training cohort, 0.931 in the internal validation cohort and 0.902 in the external cohort). CONCLUSIONS: The clinical model in this study developed a satisfied non-invasive diagnostic performance for HCC in LRP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09812-w.
format Online
Article
Text
id pubmed-9238050
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92380502022-06-29 Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population Xie, Zonglin Peng, Zhenpeng Zou, Yujian Xiao, Han Li, Bin Zhou, Qian Chen, Shuling Xu, Lixia Shen, Jingxian Mo, Yunxian Peng, Sui Kuang, Ming Long, Jianting Feng, Shi-Ting BMC Cancer Research AIMS: With prevalence of hepatocellular carcinoma (HCC) in low-risk population (LRP), establishing a non-invasive diagnostic strategy becomes increasingly urgent to spare unnecessary biopsies in this population. The purposes of this study were to find characterisics of HCC and to establish a proper non-invasive method to diagnose HCC in LRP. METHODS: A total of 681 patients in LRP (defined as the population without cirrhosis, chronic HBV infection or HCC history) were collected from 2 institutions. The images of computed tomography (CT) and magnetic resonance imaging (MRI) were manually analysed. We divided the patients into the training cohort (n = 324) and the internal validating cohort (n = 139) by admission time in the first institution. The cohort in the second institution was viewed as the external validation (n = 218). A multivariate logistic regression model incorporating both imaging and clinical independent risk predictors was developed. C-statistics was used to evaluate the diagnostic performance. RESULTS: Besides the major imaging features of HCC (non-rim enhancement, washout and enhancing capsule), tumor necrosis or severe ischemia (TNSI) on imaging and two clinical characteristics (gender and alpha fetoprotein) were also independently associated with HCC diagnosis (all P < 0.01). A clinical model (including 3 major features, TNSI, gender and AFP) was built to diagnose HCC and achieved good diagnostic performance (area under curve values were 0.954 in the training cohort, 0.931 in the internal validation cohort and 0.902 in the external cohort). CONCLUSIONS: The clinical model in this study developed a satisfied non-invasive diagnostic performance for HCC in LRP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09812-w. BioMed Central 2022-06-28 /pmc/articles/PMC9238050/ /pubmed/35761201 http://dx.doi.org/10.1186/s12885-022-09812-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xie, Zonglin
Peng, Zhenpeng
Zou, Yujian
Xiao, Han
Li, Bin
Zhou, Qian
Chen, Shuling
Xu, Lixia
Shen, Jingxian
Mo, Yunxian
Peng, Sui
Kuang, Ming
Long, Jianting
Feng, Shi-Ting
Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
title Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
title_full Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
title_fullStr Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
title_full_unstemmed Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
title_short Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
title_sort non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238050/
https://www.ncbi.nlm.nih.gov/pubmed/35761201
http://dx.doi.org/10.1186/s12885-022-09812-w
work_keys_str_mv AT xiezonglin noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT pengzhenpeng noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT zouyujian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT xiaohan noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT libin noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT zhouqian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT chenshuling noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT xulixia noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT shenjingxian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT moyunxian noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT pengsui noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT kuangming noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT longjianting noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation
AT fengshiting noninvasivediagnosisstrategyofhepatocellularcarcinomainlowriskpopulation